JP2016520133A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520133A5
JP2016520133A5 JP2016517049A JP2016517049A JP2016520133A5 JP 2016520133 A5 JP2016520133 A5 JP 2016520133A5 JP 2016517049 A JP2016517049 A JP 2016517049A JP 2016517049 A JP2016517049 A JP 2016517049A JP 2016520133 A5 JP2016520133 A5 JP 2016520133A5
Authority
JP
Japan
Prior art keywords
group
alkyl
carbon atoms
alkoxy
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016517049A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520133A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/040286 external-priority patent/WO2014194226A2/en
Publication of JP2016520133A publication Critical patent/JP2016520133A/ja
Publication of JP2016520133A5 publication Critical patent/JP2016520133A5/ja
Pending legal-status Critical Current

Links

JP2016517049A 2013-05-31 2014-05-30 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物 Pending JP2016520133A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361829759P 2013-05-31 2013-05-31
US61/829,759 2013-05-31
US201361839609P 2013-06-26 2013-06-26
US61/839,609 2013-06-26
PCT/US2014/040286 WO2014194226A2 (en) 2013-05-31 2014-05-30 Methods of treatment and compositions with xanthine oxidase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019034081A Division JP2019108356A (ja) 2013-05-31 2019-02-27 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物

Publications (2)

Publication Number Publication Date
JP2016520133A JP2016520133A (ja) 2016-07-11
JP2016520133A5 true JP2016520133A5 (enExample) 2017-07-06

Family

ID=50983231

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016517049A Pending JP2016520133A (ja) 2013-05-31 2014-05-30 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物
JP2019034081A Pending JP2019108356A (ja) 2013-05-31 2019-02-27 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019034081A Pending JP2019108356A (ja) 2013-05-31 2019-02-27 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物

Country Status (9)

Country Link
US (2) US20140357683A1 (enExample)
JP (2) JP2016520133A (enExample)
CN (1) CN105579037A (enExample)
CA (1) CA2913755A1 (enExample)
MX (1) MX2015016494A (enExample)
PH (1) PH12015502679A1 (enExample)
SG (2) SG11201509738RA (enExample)
TW (1) TW201536284A (enExample)
WO (1) WO2014194226A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016344673A1 (en) * 2015-10-28 2018-05-17 Sun Pharmaceutical Industries Limited Pharmaceutical compositions of dimethyl fumarate
CN105769766B (zh) * 2016-03-24 2018-07-06 长沙佰顺生物科技有限公司 一种托匹司他纳米乳及其制备方法
JP7108384B2 (ja) * 2016-07-13 2022-07-28 日本ケミファ株式会社 2-[3-シアノ-4-(2-メチルプロポキシ)フェニル]-4-メチルチアゾール-5-カルボン酸の口腔内崩壊錠
SG11201900405XA (en) * 2016-07-18 2019-02-27 Arthrosi Therapeutics Inc Compounds, compositions and methods for treating or preventing a sympton associated with gout or hyperuricemia
KR102946486B1 (ko) 2018-12-06 2026-03-31 아쓰로시 테라퓨틱스, 인크. 통풍 또는 고뇨산혈증의 치료 또는 예방을 위한 화합물의 결정형
WO2020118114A1 (en) 2018-12-06 2020-06-11 Arthrosi Therapeutics, Inc. Methods for treating or preventing gout or hyperuricemia
AU2020287549B2 (en) * 2019-06-04 2026-01-29 Nippon Chemiphar Co., Ltd. Therapeutic for gout or hyperuricemia
AU2022294728A1 (en) * 2021-06-15 2024-01-04 Lg Chem, Ltd. Pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid
AR126164A1 (es) * 2021-06-17 2023-09-27 Lg Chemical Ltd Formulación compuesta para dosificación oral que comprende ácido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-carboxílico
CN115252567A (zh) * 2022-07-08 2022-11-01 广西纯正堂制药有限公司 非布司他渗透泵缓释片及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478759A (en) 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US5286497A (en) 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
US5573776A (en) 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
US5544163A (en) 1994-03-08 1996-08-06 Excel, Inc. Expandable telecommunications system
SI1488790T1 (sl) 2002-03-28 2014-09-30 Teijin Pharma Limited Trden pripravek, ki vsebuje eno samo kristalno a-obliko derivata tiazolkarboksilne kisline
WO2005121153A1 (ja) * 2004-06-14 2005-12-22 Nippon Chemiphar Co., Ltd. 縮合ピリミジン誘導体、及びキサンチンオキシダーゼ阻害剤
ES2355068T3 (es) 2005-10-07 2011-03-22 Astellas Pharma Inc. Derivado del ácido triarilcarboxílico.
AU2008206231A1 (en) * 2007-01-19 2008-07-24 Takeda Pharmaceuticals U.S.A., Inc. Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents
PT2415771E (pt) 2009-03-31 2013-10-03 Kissei Pharmaceutical Derivado de indolizina e sua utilização para fins médicos
CN101773498B (zh) * 2009-12-30 2012-06-20 青岛黄海制药有限责任公司 一种含有非布司他的口服缓控释制剂的制备方法
US8968779B2 (en) 2010-06-16 2015-03-03 Teijin Pharma Limited Controlled release coat-core tablet
US9248119B2 (en) * 2010-06-16 2016-02-02 Takeda Pharmaceuticals U.S.A., Inc. Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
CN102641255A (zh) * 2012-05-08 2012-08-22 南方医科大学 一种治疗痛风的非布索坦渗透泵控释片及其制备方法

Similar Documents

Publication Publication Date Title
RU2011143741A (ru) Производное индолизина и его применение в медицинских целях
JP2016512520A5 (enExample)
PH12019500395A1 (en) Amino-pyrrolopyrimidinone compounds and methods of use thereof
JP2011513305A5 (enExample)
JP2016515561A5 (enExample)
JP2013531029A5 (enExample)
JP2013528655A5 (enExample)
JP2016518437A5 (enExample)
JP2012508252A5 (enExample)
JP2017537940A5 (enExample)
JP2014504622A5 (enExample)
JP2012184234A5 (enExample)
JP2012041349A5 (enExample)
JP2015522650A5 (enExample)
ZA201802312B (en) A group of compounds used for the treatment or prevention of hyperuricemia or gout
JP2013508288A5 (enExample)
JP2018533593A5 (enExample)
JP2016507575A5 (enExample)
JP2013063968A5 (enExample)
MX339829B (es) Metodo para estabilizar daño de articulacion en sujetos utilizando inhibidores de xantina oxidoreductasa.
RU2018101431A (ru) Ингибиторы индоламин-2,3-диоксигеназы
JP2015521156A5 (enExample)
JP2017510660A5 (enExample)
RU2016142611A (ru) Пролекарственные средства ингибиторов обратной транскриптазы вич
MX388175B (es) Compuestos terapéuticos y métodos para utilizarlos